Skip to main content

Animations

MJFF Publications

951 - 960 of 5882 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • OPEN
    Title: Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson’s disease
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-023-37464-2
    Citation Count: 27
  • OPEN
    Title: Cerebral white matter rarefaction has both neurodegenerative and vascular causes and may primarily be a distal axonopathy
    Journal Name: Journal of Neuropathology & Experimental Neurology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/jnen/nlad026
    Best OA location URL:
    Citation Count: 10
  • OPEN
    Title: Episodic memory deficit in HIV infection: common phenotype with Parkinson’s disease, different neural substrates
    Journal Name: Brain Structure and Function
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00429-023-02626-x
    Citation Count: 1
  • OPEN
    Title: Intermediate Deformable Image Registration Via Windowed Cross-Correlation
    Journal Name: 2023 IEEE 20th International Symposium on Biomedical Imaging (ISBI)
    Publisher: IEEE
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1109/isbi53787.2023.10230715
    Citation Count: 0
  • OPEN
    Title: Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00497-x
    Citation Count: 55
  • OPEN
    Title: Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00109-6
    Citation Count: 347
  • OPEN
    Title: In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson’s disease using neuromelanin-sensitive MRI: Replication in two cohorts
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0282684
    Citation Count: 10
  • OPEN
    Title: Targeted Extracellular Vesicle Gene Therapy for Modulating Alpha-Synuclein Expression in Gut and Spinal Cord
    Journal Name: Pharmaceutics
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/pharmaceutics15041230
    Citation Count: 6
  • OPEN
    Title: USP8 Down-Regulation Promotes Parkin-Independent Mitophagy in the Drosophila Brain and in Human Neurons
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells12081143
    Citation Count: 1
  • OPEN
    Title: Capturing Differences in the Regulation of LRRK2 Dynamics and Conformational States by Small Molecule Kinase Inhibitors
    Journal Name: ACS Chemical Biology
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acschembio.2c00868
    Citation Count: 13
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.